Brief: Oncopeptides Q2 Operating Profit SEK -48.668 Million
27/08/2026 07:01
BRIEF-Oncopeptides Q2 Operating Profit SEK -48.668 Million Aug 27 (Reuters) - Oncopeptides Q2 net income SEK -54.712 million.
- Q2 adjusted EPS SEK -0.14
- Q2 adjusted free cash flow SEK -42.811 million
- Q2 sales SEK 31.099 million
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy